Neurology · 2000 · 54 citations · 5 references
MedicinePharmacologyPharmacotherapyEpilepsyNeuropharmacologyPediatric NeurologyAntiepileptic PharmacologyAntiepileptic PharmacotherapyGabaergic NeurochemistryGabaergic PharmacologyGabaergic SignalingGenetic EpilepsiesAngelman SyndromeAnticonvulsant PharmacologyGaba Receptor GenesGabaergic DysfunctionGabaergic Neurotransmission ModulationGabaergic Role In EpilepsyPediatric Epilepsy PharmacotherapyTopiramate Therapy
Angelman's syndrome, a genetic disorder involving a defect in the DNA coding for subunits of the gamma-aminobutyric acid (GABA) type A receptor, often is associated with intractable epilepsy. Topiramate is a novel anticonvulsant that enhances GABAergic neurotransmission. Five children with Angelman's syndrome and epilepsy were treated with topiramate for clinical indications. The drug was effective and well tolerated, possibly because of its GABAergic properties. Further studies are necessary to confirm and elucidate this observation.
5
Angelman syndrome: Correlations between epilepsy phenotypes and genotypes
Berge A. Minassian, Timothy M. DeLorey, Richard W. Olsen et al. · Annals of Neurology · 1998 · 193 citations
Jill Clayton‐Smith, Marcus Pembrey · Journal of Medical Genetics · 1992 · 174 citations · Full text
Medicine, Pediatrics, Psychiatry +9
Adverse Effects of Vigabatrin in Angelman Syndrome
Ch. Kuenzle, Maja Steinlin, Gabriele Wohlrab et al. · Epilepsia · 1998 · 43 citations